{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:49:45Z","timestamp":1792514985611,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Panic disorder (PD) significantly impacts individuals\u2019 daily lives and overall well-being. While cognitive behavioral therapy (CBT) is the gold standard for PD treatment, there is a growing interest in brief interventions to improve accessibility and reduce treatment burden. This study explored the feasibility and preliminary outcomes of a brief, four-session CBT intervention for PD, grounded in an intention-focused approach. The treatment emphasized modifying patients\u2019 intentions underlying avoidance and safety behaviors during exposure tasks, aiming to enhance engagement and therapeutic effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This naturalistic effectiveness study involved 27 patients from the Norwegian Specialist Health Care clinic who were referred for PD treatment. Participants received the Bergen Repeated One-Session Treatment (BrOST), a brief, intention-focused cognitive behavioral intervention delivered in four individual sessions over a period of two to three weeks. Standardized self-report measures were administered to assess the severity of panic symptoms, general anxiety, depressive symptoms, and treatment satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The treatment resulted in significant reductions in PD severity from pretreatment to one week posttreatment, with sustained improvements at three months. There were also notable reductions in symptoms of anxiety and depression. High levels of treatment satisfaction were reported by the patients. These findings suggest that the BrOST could be a promising alternative to traditional CBT protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicated that the BrOST may be a promising brief CBT intervention for individuals with PD. Larger and more controlled studies are warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was reviewed by the Regional Committee for Medical Research Ethics Northern Norway, REK North (REK Midt 2023\/ 701114).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-025-07499-4","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:21:48Z","timestamp":1767792108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Brief treatments for panic disorder: a pilot study of the bergen repeated one-session treatment format"],"prefix":"10.1186","volume":"26","author":[{"given":"Bjarne","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Morten","family":"Hjelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thr\u00f6stur","family":"Bj\u00f6rgvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Erland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"7499_CR1","doi-asserted-by":"crossref","unstructured":"Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415\u201324.","DOI":"10.1001\/archpsyc.63.4.415"},{"key":"7499_CR2","unstructured":"National Institute for Health and Care Excellence. Generalized anxiety disorder and panic disorder in adults. Clinical Guideline CG113. London; 2020."},{"key":"7499_CR3","doi-asserted-by":"crossref","unstructured":"\u00d6st LG, Ollendick TH. Brief, Intensive and Concentrated Cognitive Behavioral Treatments for Anxiety Disorders in Children: A Systematic Review and Meta-Analysis. Behav Res Ther. 2017;97:134\u201345.","DOI":"10.1016\/j.brat.2017.07.008"},{"key":"7499_CR4","unstructured":"Varma S. Ultra-short Term Cognitive Behaviour Psychotherapy for Panic Attacks. Malaysian Journal of Psychiatry. 1997;5(1):34\u201340."},{"key":"7499_CR5","doi-asserted-by":"crossref","unstructured":"Westling BE, \u00d6st L-G. Brief cognitive behaviour therapy of panic disorder. Scandinavian Journal of Behaviour Therapy. 1999;28(2):49\u201357.","DOI":"10.1080\/028457199440007"},{"key":"7499_CR6","doi-asserted-by":"crossref","unstructured":"Craske MG, Maidenberg E, Bystritsky A. Brief cognitive-behavioral versus nondirective therapy for panic disorder. J Behav Ther Exp Psychiatry. 1995;26(2):113\u201320.","DOI":"10.1016\/0005-7916(95)00003-I"},{"key":"7499_CR7","doi-asserted-by":"crossref","unstructured":"Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M. Brief cognitive therapy for panic disorder: a randomized controlled trial. Journal of Consulting and Clinical Psychology. 1999;67(4):583.","DOI":"10.1037\/\/0022-006X.67.4.583"},{"key":"7499_CR8","doi-asserted-by":"crossref","unstructured":"Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, et al. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010;67(4):365\u201370.","DOI":"10.1016\/j.biopsych.2009.07.036"},{"key":"7499_CR9","doi-asserted-by":"crossref","unstructured":"Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, et al. Randomized trial of d\u2010cycloserine enhancement of cognitive\u2010behavioral therapy for panic disorder. Depress Anxiety. 2016;33(8):737\u201345.","DOI":"10.1002\/da.22531"},{"key":"7499_CR10","doi-asserted-by":"crossref","unstructured":"Davidsdottir SD, Sigurjonsdottir O, Ludvigsdottir SJ, Kvale G, Hansen B, Hagen K, et al. Preliminary effectiveness of the Bergen 4-day treatment for OCD in Iceland. Cognitive behaviour therapy. 2025;54(5):1\u201318.","DOI":"10.1080\/16506073.2025.2453722"},{"key":"7499_CR11","doi-asserted-by":"crossref","unstructured":"Skjold SH, Hagen K, Wheaton MG, Hjelle KM, Bjorgvinsson T, Hansen B. The effectiveness and acceptability of the Bergen 4-day treatment for adolescents with OCD: a replication and extension. BMC Psychiatry. 2024;24(1):148.","DOI":"10.1186\/s12888-024-05601-w"},{"key":"7499_CR12","doi-asserted-by":"crossref","unstructured":"Jelinek L, Serve A, Pampuch S, Scheunemann J, Schultz J, Miegel F, et al. Exploring the Peaks and Potholes: Understanding positive and negative effects of concentrated exposure treatment for obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders. 2024;43:100913.","DOI":"10.1016\/j.jocrd.2024.100913"},{"key":"7499_CR13","doi-asserted-by":"crossref","unstructured":"Launes G, Hagen K, \u00d6st LG, Solem S, Hansen B, Kvale G. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention. Front Psychol. 2020;11:982.","DOI":"10.3389\/fpsyg.2020.00982"},{"key":"7499_CR14","doi-asserted-by":"crossref","unstructured":"Kvale G, Hansen B, Hagen K, Abramowitz JS, Bortveit T, Craske MG, Franklin ME, Haseth S, Himle JA, Hystad S et al. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(8):e2013249.","DOI":"10.1001\/jamanetworkopen.2020.13249"},{"key":"7499_CR15","doi-asserted-by":"crossref","unstructured":"Launes G, Laukvik IL, Sunde T, Klovning I, Hagen K, Solem S, et al. The Bergen 4-Day Treatment for Obsessive-Compulsive Disorder: Does It Work in a New Clinical Setting? Front Psychol. 2019;10:1069.","DOI":"10.3389\/fpsyg.2019.01069"},{"key":"7499_CR16","doi-asserted-by":"crossref","unstructured":"Launes G, Hagen K, Sunde T, Ost LG, Klovning I, Laukvik IL, et al. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment. Front Psychol. 2019;10:2500.","DOI":"10.3389\/fpsyg.2019.02500"},{"key":"7499_CR17","doi-asserted-by":"crossref","unstructured":"Hansen B, Kvale G, Hagen K, Havnen A, \u00d6st LG. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cognitive behaviour therapy. 2019;48(2):89\u2013105.","DOI":"10.1080\/16506073.2018.1478447"},{"key":"7499_CR18","unstructured":"Dav\u00ed\u00f0sd\u00f3ttir SD, Sigurj\u00f3nsd\u00f3ttir \u00d3, Ludvigsd\u00f3ttir SJ, Hansen B, Laukvik IL, Hagen K, et al. Implementation of the Bergen 4-day treatment for obsessive compulsive disorder in Iceland. Clin Neuropsychiatry. 2019;16(1):33\u20138."},{"key":"7499_CR19","doi-asserted-by":"crossref","unstructured":"Kvale G, Hansen B, Bj\u00f6rgvinsson T, Bortveit T, Hagen K, Haseth S, et al. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry. 2018;18(1):323.","DOI":"10.1186\/s12888-018-1887-4"},{"key":"7499_CR20","doi-asserted-by":"crossref","unstructured":"Hansen B, Hagen K, Ost LG, Solem S, Kvale G. The Bergen 4-Day OCD Treatment Delivered in a Group Setting: 12-Month Follow-Up. Front Psychol. 2018;9:639.","DOI":"10.3389\/fpsyg.2018.00639"},{"key":"7499_CR21","doi-asserted-by":"crossref","unstructured":"Eide TO, Olsen T, Hansen H, Hansen B, Solem S, Hagen K. The Bergen 4-Day Treatment for panic disorder patients in a rural clinical setting: a long-term follow-up study. BMC Psychiatry. 2025;25(1):3.","DOI":"10.1186\/s12888-024-06445-0"},{"key":"7499_CR22","doi-asserted-by":"crossref","unstructured":"Eide TO, Hansen B, Hjelle KM, Solem S, Wheaton MG, Bj\u00f6rgvinsson T, et al. The bergen 4-day treatment for panic disorder: a longer-term follow-up. BMC Psychiatry. 2025;25(1):107.","DOI":"10.1186\/s12888-025-06527-7"},{"key":"7499_CR23","doi-asserted-by":"crossref","unstructured":"Hjelle KM, Eide TO, Thorsen AL, Kvale G, Hagen K, Wheaton MG, et al. Long-term follow-up of the Bergen 4-day treatment for panic disorder during the COVID-19 pandemic. Cogent Psychology. 2024;11(1):2402603.","DOI":"10.1080\/23311908.2024.2402603"},{"key":"7499_CR24","doi-asserted-by":"crossref","unstructured":"Hjelle KM, Eide TO, Thorsen AL, Kvale G, Hagen K, Snorrason I, et al. The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities. BMC Psychiatry. 2023;23(1):570.","DOI":"10.1186\/s12888-023-05062-7"},{"key":"7499_CR25","doi-asserted-by":"crossref","unstructured":"Eide TO, Hjelle KM, Saetre IU, Solem S, Olsen T, Skold RO, et al. The Bergen 4-day treatment for panic disorder: implementation in a rural clinical setting. BMC Psychiatry. 2023;23(1):305.","DOI":"10.1186\/s12888-023-04812-x"},{"key":"7499_CR26","doi-asserted-by":"crossref","unstructured":"Iversen HM, Eide TO, Harvold M, Solem S, Kvale G, Hansen B, Hagen K. The Bergen 4-day treatment for panic disorder: replication and implementation in a new clinic. BMC Psychiatry. 2022;22(1):728.","DOI":"10.1186\/s12888-022-04380-6"},{"key":"7499_CR27","doi-asserted-by":"crossref","unstructured":"Hansen B, Kvale G, Hagen K, Hjelle KM, Solem S, B\u00f8 B, \u00d6st LG. The Bergen 4-Day Treatment for Panic Disorder: A Pilot Study. Front Psychol. 2018;9:1044.","DOI":"10.3389\/fpsyg.2018.01044"},{"key":"7499_CR28","doi-asserted-by":"crossref","unstructured":"Hansen B, Olsen Eide T, Reir\u00e5skag MA, Tjelle KA, Solem S, Hagen K. The Bergen 4-Day Treatment for Social Anxiety Disorder: A Pilot Study. BMC Psychiatry. 2024;24(145).","DOI":"10.1186\/s12888-024-05607-4"},{"key":"7499_CR29","doi-asserted-by":"crossref","unstructured":"Clark DM, Ehlers A. An overview of the cognitive theory and treatment of panic disorder. Applied and preventive psychology. 1993;2(3):131\u20139.","DOI":"10.1016\/S0962-1849(05)80119-2"},{"key":"7499_CR30","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333;quiz 34\u201357."},{"key":"7499_CR31","doi-asserted-by":"crossref","unstructured":"Mordal J, Gundersen \u00d8, Bramness JG. Norwegian version of the Mini-International Neuropsychiatric Interview: feasibility, acceptability and test-retest reliability in an acute psychiatric ward. Eur Psychiatry. 2010;25(3):172\u20137.","DOI":"10.1016\/j.eurpsy.2009.02.004"},{"key":"7499_CR32","doi-asserted-by":"crossref","unstructured":"Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154(11):1571\u20135.","DOI":"10.1176\/ajp.154.11.1571"},{"key":"7499_CR33","doi-asserted-by":"crossref","unstructured":"Wuyek LA, Antony MM, McCabe RE. Psychometric properties of the Panic Disorder Severity Scale. Clinician\u2010administered and self\u2010report versions. Clin Psychol Psychother. 2011;18(3):234\u201343.","DOI":"10.1002\/cpp.703"},{"key":"7499_CR34","doi-asserted-by":"crossref","unstructured":"Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, Etschel E, Engel RR, Leucht S. Evidence\u2010based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety. 2009;26(10):922\u20139.","DOI":"10.1002\/da.20532"},{"key":"7499_CR35","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","DOI":"10.1016\/j.genhosppsych.2010.03.006"},{"key":"7499_CR36","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine. 2006;166(10):1092\u20131097.","DOI":"10.1001\/archinte.166.10.1092"},{"key":"7499_CR37","doi-asserted-by":"crossref","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207.","DOI":"10.1016\/0149-7189(79)90094-6"},{"key":"7499_CR38","doi-asserted-by":"crossref","unstructured":"Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. Journal of evaluation in clinical practice. 2004;10(2):307\u201312.","DOI":"10.1111\/j..2002.384.doc.x"},{"key":"7499_CR39","doi-asserted-by":"crossref","unstructured":"Schafer JL. Analysis of incomplete multivariate data. Thousand Oaks, CA: Sage; 1997.","DOI":"10.1201\/9781439821862"},{"key":"7499_CR40","doi-asserted-by":"crossref","unstructured":"Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological methods. 2002;7(1):105\u2013125.","DOI":"10.1037\/\/1082-989X.7.1.105"},{"key":"7499_CR41","doi-asserted-by":"crossref","unstructured":"Pedersen H, Havnen A, Brattmyr M, Attkisson CC, Lara-Cabrera ML. A digital Norwegian version of the client satisfaction questionnaire 8: factor validity and internal reliability in outpatient mental health care. BMC Psychiatry. 2022;22(1):671.","DOI":"10.1186\/s12888-022-04281-8"},{"key":"7499_CR42","doi-asserted-by":"crossref","unstructured":"Shafran R, Clark DM, Fairburn CG, Arntz A, Barlow DH, Ehlers A, et al.\u00a0Mind the gap: Improving the dissemination of CBT.\u00a0Behav Res Ther. 2009;47(11):902\u20139.","DOI":"10.1016\/j.brat.2009.07.003"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07499-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07499-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07499-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:21:57Z","timestamp":1767792117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07499-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7499"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07499-4","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles outlined in the Declaration of Helsinki and was approved by the Regional Committee for Medical Research Ethics Northern Norway, REK North (REK Midt-2023\/701114). Informed written consent was obtained from all participants. The participants were informed that participation in the study was voluntary and that they had the right to withdraw from the study at any time without any negative effect on their treatment. All methods were performed in accordance with the relevant guidelines and regulations, including the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}